Facebook Linkedin Twitter
Inside Precision Medicine BMS Pays $100M Upfront for Antibody Degrader Conjugate from Orum

BioNTech

3D Rendering of Antibody Drug Conjugate Molecules
News & Features

BMS Pays $100M Upfront for Antibody Degrader Conjugate from Orum

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

BioNTech Nets MediLink ADC in Potential $1B Cancer Deal

0
Oncologist Discussing Medications with a Senior Patient
News & Features

Moderna Will Collaborate with CARsgen to Develop Combined CAR-T Cancer Vaccine

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

BMS and Tubulis Ink Potential $1B+ Deal around ADCs

0
Bladder Cancer
News & Features

First ADC/Immuno-Oncology Combination Approved for Urothelial Cancer

0
cancer-associated fibroblasts
News & Features

BioNTech Inks Potential $1.5 Billion+ ADC Deal with Duality Biologics

0
3d illustration of a part of an RNA chain to illustrate new RNA therapeutics
Molecular Dx

Research Brings Programmable RNA Therapies Closer to Clinic

0
Delivering a New “Post-COVID” Generation of RNA Therapeutics
Coronavirus

Delivering a New “Post-COVID” Generation of RNA Therapeutics

Helen Albert
0
3d illustration of a part of an RNA chain to illustrate new RNA therapeutics
Molecular Dx

Five RNA Therapeutics Startups to Watch in 2022

Helen Albert
0
Global virus and disease spread, coronavirus
Coronavirus

BioNTech Develops Successful SARS-CoV-2 Early Warning System with InstaDeep

0
123...5Page 2 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine